BMS 215 (Daklinza 60 mg)
Generic Name: daclatasvir
Pill imprint BMS 215 has been identified as Daklinza 60 mg.
Daklinza is used in the treatment of hepatitis c and belongs to the drug class NS5A inhibitors. Daklinza 60 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Daklinza (daclatasvir)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.